2022
DOI: 10.1016/j.jddst.2022.103252
|View full text |Cite
|
Sign up to set email alerts
|

Smart releasing CuS/ZnS nanocomposite dual drug carrier and photothermal agent for use as a theranostic tool for cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…Finally, PTT combined with dual-drug chemotherapy significantly reduced tumor growth. [33] The accumulation of drugs in tumor tissues may be improved by altering the targeting ligands on the surface of drug delivery nanocarriers. One standard method of deliv-ering drugs into tumor cells involves coupling the drugs to specific ligands and actively targeting the cells.…”
Section:  Chemotherapymentioning
confidence: 99%
“…Finally, PTT combined with dual-drug chemotherapy significantly reduced tumor growth. [33] The accumulation of drugs in tumor tissues may be improved by altering the targeting ligands on the surface of drug delivery nanocarriers. One standard method of deliv-ering drugs into tumor cells involves coupling the drugs to specific ligands and actively targeting the cells.…”
Section:  Chemotherapymentioning
confidence: 99%
“…For example, transition metal dichalcogenide-based molybdenum disulfide (MoS 2 -) and tungsten disulfide (WS 2 -) NPs are increasingly found in theranostic and biosensing applications [ 12 , 13 ]. Tunable bandgap and strong spin-orbit coupling make MoS 2 -NPs particularly interesting for biomedical applications, whereas strong near-infrared (NIR) absorptions has led to the efficacious use of copper sulfide (CuS-) NPs as photothermal agents [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%